6505--Simvastatin Tablets (VA-26-00009813)

The contract involves the procurement of Simvastatin Tablets in multiple dosages and packaging configurations, intended for supply to the Department of Veterans Affairs and other federal agencies such as DOD, BOP, and IHS. The solicitation, issued by the VA National Acquisition Center, is structured as a Request for Quotation (RFQ) with a posting date of October 31, 2025, and a deadline for responses set for November 18, 2025, which was later extended to November 25, 2025. The procurement encompasses a base year plus four one-year option periods, with the contract to be awarded on an aggregate basis to the lowest evaluated price proposal that meets all technical and compliance standards. The NAICS code assigned is 325412, indicating a focus on pharmaceutical manufacturing. Key technical requirements emphasize strict packaging, labeling, and stability standards. Packaging must utilize unit-of-use bottles with child-resistant safety caps, meet specific size and labeling dimensions, and incorporate barcodes compliant with GS1 or HIBCC standards, including encoding the National Drug Code (NDC), lot number, and expiration date. Labels must be free of overlays, and bottles must be glass-free, with stability testing ensuring product integrity during storage and transport. The contract clauses include standard FAR provisions related to labor standards, trafficking in persons, trade restrictions, and foreign acquisition limitations, with specific clauses addressing fair labor practices, wage adjustments, and trade compliance. The award process will prioritize the lowest price among proposals that satisfy all non-cost technical and compliance criteria, following a Lowest Price Technically Acceptable approach. The solicitation also details administrative procedures for proposal submission, including electronic delivery via email, with no specified page limits but requiring a signed SF-1449 form and supporting documentation. Contract administration will involve designated points of contact for payment, oversight, and performance monitoring, with specific invoicing and reporting procedures to be clarified upon award. Overall, the contract aims to ensure a reliable supply of high-quality Simvastatin Tablets, adhering to rigorous packaging, labeling, and regulatory standards, with a focus on cost-effectiveness and compliance with federal acquisition regulations.